HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE

Clinical trials for HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE explained in plain language.

Never miss a new study

Get alerted when new HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE trials appear

Sign up with your email to follow new studies for HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough breast cancer: experimental combo enters human testing

Disease control Ongoing

This study is testing a new drug called azenosertib, combined with two existing cancer drugs, for people with advanced triple-negative breast cancer that has spread. The main goals are to find a safe dose and see if the combination makes tumors shrink. About 78 participants will …

Matched conditions: HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE

Phase: PHASE1, PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE

Get alerted when new HORMONE RECEPTOR NEGATIVE MALIGNANT TUMOR BREAST TRIPLE trials appear

New hope for tough breast cancer: experimental combo enters human testing